HPV serologic testing for the study entitled "prospective evaluation of HPV prior to diagnosis of incident head and neck cancer and anogenital cancer".

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700539P
Awardee
Awarding agency
Obligated
$20,026

Award facts

Contract value 100% obligated
$20,026.05 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Deutsches Krebsforschungszentrum (DKFZ) valued at $20,026.05 on August 21, 2017, for HPV serologic testing in support of a prospective study evaluating HPV prior to diagnosis of incident head and neck cancer and anogenital cancer. Work is performed in Germany under firm fixed price terms, with completion targeted for August 31, 2018. No set-aside was applied to this procurement.

Quick answers

Who was awarded contract HHSN261201700539P?

HHSN261201700539P was awarded to Deutsches Krebsforschungszentrum by National Cancer Institute (National Institutes of Health) on August 21, 2017.

How much is contract HHSN261201700539P worth?

The government has obligated $20,026 on HHSN261201700539P.

Was contract HHSN261201700539P competed?

The extent of competition for HHSN261201700539P was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login